To include your compound in the COVID-19 Resource Center, submit it here.

Reprise for RaQualia

Pfizer spinout RaQualia back on track for IPO in Japan

Japan's RaQualia Pharma Inc. revived its IPO plans and now expects to go public next month with an enlarged deal. The plans had been on hold since the Japanese

Read the full 299 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers